 | • レポートコード：QAF27800 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のナタマイシン市場について種類別（ナタマイシン50％、ナタマイシン95％）、用途別（食品産業、医療、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ナタマイシン市場の概要 ・世界の主要地域別ナタマイシン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のナタマイシン市場規模2016-2021：種類別（ナタマイシン50％、ナタマイシン95％） ・世界のナタマイシン市場予測2012-2027：種類別（ナタマイシン50％、ナタマイシン95％） ・世界のナタマイシン市場規模2016-2021：用途別（食品産業、医療、その他） ・世界のナタマイシン市場予測2012-2027：用途別（食品産業、医療、その他） ・ナタマイシンのアメリカ市場規模と予測2016-2021 ・ナタマイシンのヨーロッパ市場規模と予測2016-2021 ・ナタマイシンの中国市場規模と予測2016-2021 ・ナタマイシンの日本市場規模と予測2016-2021 ・ナタマイシンの東南アジア市場規模と予測2016-2021 ・ナタマイシンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Danisco、DSM、VGP、Handary、AMTECH BIOTECH、Silver-Elephant、Lanzhou Weiri、Langfang Meihua、Zhengzhou New Frey、Chihon、Jiaozuo Joincare、Beijing Oriental Rada、Pucheng Lifecome） ・ナタマイシンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナタマイシンの市場動向・機会・課題 ・調査の結論 |
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Raw Materials are important component, occupying for the most proportion of cost. It’s important and necessary to attach importance to raw materials sourcing.
In general, the raw materials need to outsourcing, and the price, on-time rate and quality are very key indicators, to keep competitive market position, to maximize the profit.
Actually, the price, on-time rate or quality, is just one of key factors to influence on the supply capacity and competitiveness. The lowest total production cost is the total index to maximize the profit.
To a producer, can control the total production cost through worldwide procurement, localization procurement and concentrative purchase, more purchasing focuses on fewer suppliers to large-scale purchase, to large-scale and high efficiency. Now the logistics and information is well-developed, beneficial to worldwide procurement, localization procurement and concentrative purchase. In future, more manufacturers will attach importance to the raw materials purchasing,
Market Analysis and Insights: Global Natamycin Market
The global Natamycin market was valued at US$ 185.5 in 2020 and will reach US$ 269.2 million by the end of 2027, growing at a CAGR of 6.4% during 2022-2027.
Global Natamycin Scope and Market Size
The global Natamycin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Natamycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Natamycin 50%
Natamycin 95%
Segment by Application
Food Industry
Medical
Others
The Natamycin market is analysed and market size information is provided by regions (countries). Segment by Application, the Natamycin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
1 Natamycin Market Overview
1.1 Natamycin Product Scope
1.2 Natamycin Segment by Type
1.2.1 Global Natamycin Sales by Type (2016 & 2021 & 2027)
1.2.2 Natamycin 50%
1.2.3 Natamycin 95%
1.3 Natamycin Segment by Application
1.3.1 Global Natamycin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Food Industry
1.3.3 Medical
1.3.4 Others
1.4 Natamycin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Natamycin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Natamycin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Natamycin Price Trends (2016-2027)
2 Natamycin Estimates and Forecasts by Region
2.1 Global Natamycin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Natamycin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Natamycin Sales Market Share by Region (2016-2021)
2.2.2 Global Natamycin Revenue Market Share by Region (2016-2021)
2.3 Global Natamycin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Natamycin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Natamycin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Natamycin Estimates and Projections (2016-2027)
2.4.2 Europe Natamycin Estimates and Projections (2016-2027)
2.4.3 China Natamycin Estimates and Projections (2016-2027)
2.4.4 Japan Natamycin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Natamycin Estimates and Projections (2016-2027)
2.4.6 India Natamycin Estimates and Projections (2016-2027)
3 Global Natamycin Competition Landscape by Players
3.1 Global Top Natamycin Players by Sales (2016-2021)
3.2 Global Top Natamycin Players by Revenue (2016-2021)
3.3 Global Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natamycin as of 2020)
3.4 Global Natamycin Average Price by Company (2016-2021)
3.5 Manufacturers Natamycin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Natamycin Market Size by Type
4.1 Global Natamycin Historic Market Review by Type (2016-2021)
4.1.1 Global Natamycin Sales Market Share by Type (2016-2021)
4.1.2 Global Natamycin Revenue Market Share by Type (2016-2021)
4.1.3 Global Natamycin Price by Type (2016-2021)
4.2 Global Natamycin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Natamycin Sales Forecast by Type (2022-2027)
4.2.2 Global Natamycin Revenue Forecast by Type (2022-2027)
4.2.3 Global Natamycin Price Forecast by Type (2022-2027)
5 Global Natamycin Market Size by Application
5.1 Global Natamycin Historic Market Review by Application (2016-2021)
5.1.1 Global Natamycin Sales Market Share by Application (2016-2021)
5.1.2 Global Natamycin Revenue Market Share by Application (2016-2021)
5.1.3 Global Natamycin Price by Application (2016-2021)
5.2 Global Natamycin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Natamycin Sales Forecast by Application (2022-2027)
5.2.2 Global Natamycin Revenue Forecast by Application (2022-2027)
5.2.3 Global Natamycin Price Forecast by Application (2022-2027)
6 North America Natamycin Market Facts & Figures
6.1 North America Natamycin Sales by Company
6.1.1 North America Natamycin Sales by Company (2016-2021)
6.1.2 North America Natamycin Revenue by Company (2016-2021)
6.2 North America Natamycin Sales Breakdown by Type
6.2.1 North America Natamycin Sales Breakdown by Type (2016-2021)
6.2.2 North America Natamycin Sales Breakdown by Type (2022-2027)
6.3 North America Natamycin Sales Breakdown by Application
6.3.1 North America Natamycin Sales Breakdown by Application (2016-2021)
6.3.2 North America Natamycin Sales Breakdown by Application (2022-2027)
7 Europe Natamycin Market Facts & Figures
7.1 Europe Natamycin Sales by Company
7.1.1 Europe Natamycin Sales by Company (2016-2021)
7.1.2 Europe Natamycin Revenue by Company (2016-2021)
7.2 Europe Natamycin Sales Breakdown by Type
7.2.1 Europe Natamycin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Natamycin Sales Breakdown by Type (2022-2027)
7.3 Europe Natamycin Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Natamycin Market Facts & Figures
8.1 China Natamycin Sales by Company
8.1.1 China Natamycin Sales by Company (2016-2021)
8.1.2 China Natamycin Revenue by Company (2016-2021)
8.2 China Natamycin Sales Breakdown by Type
8.2.1 China Natamycin Sales Breakdown by Type (2016-2021)
8.2.2 China Natamycin Sales Breakdown by Type (2022-2027)
8.3 China Natamycin Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Natamycin Market Facts & Figures
9.1 Japan Natamycin Sales by Company
9.1.1 Japan Natamycin Sales by Company (2016-2021)
9.1.2 Japan Natamycin Revenue by Company (2016-2021)
9.2 Japan Natamycin Sales Breakdown by Type
9.2.1 Japan Natamycin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Natamycin Sales Breakdown by Type (2022-2027)
9.3 Japan Natamycin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Natamycin Market Facts & Figures
10.1 Southeast Asia Natamycin Sales by Company
10.1.1 Southeast Asia Natamycin Sales by Company (2016-2021)
10.1.2 Southeast Asia Natamycin Revenue by Company (2016-2021)
10.2 Southeast Asia Natamycin Sales Breakdown by Type
10.2.1 Southeast Asia Natamycin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Natamycin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Natamycin Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Natamycin Market Facts & Figures
11.1 India Natamycin Sales by Company
11.1.1 India Natamycin Sales by Company (2016-2021)
11.1.2 India Natamycin Revenue by Company (2016-2021)
11.2 India Natamycin Sales Breakdown by Type
11.2.1 India Natamycin Sales Breakdown by Type (2016-2021)
11.2.2 India Natamycin Sales Breakdown by Type (2022-2027)
11.3 India Natamycin Sales Breakdown by Application
11.3.1 India Natamycin Sales Breakdown by Application (2016-2021)
11.3.2 India Natamycin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Natamycin Business
12.1 Danisco
12.1.1 Danisco Corporation Information
12.1.2 Danisco Business Overview
12.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Danisco Natamycin Products Offered
12.1.5 Danisco Recent Development
12.2 DSM
12.2.1 DSM Corporation Information
12.2.2 DSM Business Overview
12.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 DSM Natamycin Products Offered
12.2.5 DSM Recent Development
12.3 VGP
12.3.1 VGP Corporation Information
12.3.2 VGP Business Overview
12.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 VGP Natamycin Products Offered
12.3.5 VGP Recent Development
12.4 Handary
12.4.1 Handary Corporation Information
12.4.2 Handary Business Overview
12.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Handary Natamycin Products Offered
12.4.5 Handary Recent Development
12.5 AMTECH BIOTECH
12.5.1 AMTECH BIOTECH Corporation Information
12.5.2 AMTECH BIOTECH Business Overview
12.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AMTECH BIOTECH Natamycin Products Offered
12.5.5 AMTECH BIOTECH Recent Development
12.6 Silver-Elephant
12.6.1 Silver-Elephant Corporation Information
12.6.2 Silver-Elephant Business Overview
12.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Silver-Elephant Natamycin Products Offered
12.6.5 Silver-Elephant Recent Development
12.7 Lanzhou Weiri
12.7.1 Lanzhou Weiri Corporation Information
12.7.2 Lanzhou Weiri Business Overview
12.7.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Lanzhou Weiri Natamycin Products Offered
12.7.5 Lanzhou Weiri Recent Development
12.8 Langfang Meihua
12.8.1 Langfang Meihua Corporation Information
12.8.2 Langfang Meihua Business Overview
12.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Langfang Meihua Natamycin Products Offered
12.8.5 Langfang Meihua Recent Development
12.9 Zhengzhou New Frey
12.9.1 Zhengzhou New Frey Corporation Information
12.9.2 Zhengzhou New Frey Business Overview
12.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zhengzhou New Frey Natamycin Products Offered
12.9.5 Zhengzhou New Frey Recent Development
12.10 Chihon
12.10.1 Chihon Corporation Information
12.10.2 Chihon Business Overview
12.10.3 Chihon Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Chihon Natamycin Products Offered
12.10.5 Chihon Recent Development
12.11 Jiaozuo Joincare
12.11.1 Jiaozuo Joincare Corporation Information
12.11.2 Jiaozuo Joincare Business Overview
12.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Jiaozuo Joincare Natamycin Products Offered
12.11.5 Jiaozuo Joincare Recent Development
12.12 Beijing Oriental Rada
12.12.1 Beijing Oriental Rada Corporation Information
12.12.2 Beijing Oriental Rada Business Overview
12.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Beijing Oriental Rada Natamycin Products Offered
12.12.5 Beijing Oriental Rada Recent Development
12.13 Pucheng Lifecome
12.13.1 Pucheng Lifecome Corporation Information
12.13.2 Pucheng Lifecome Business Overview
12.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Pucheng Lifecome Natamycin Products Offered
12.13.5 Pucheng Lifecome Recent Development
13 Natamycin Manufacturing Cost Analysis
13.1 Natamycin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Natamycin
13.4 Natamycin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Natamycin Distributors List
14.3 Natamycin Customers
15 Market Dynamics
15.1 Natamycin Market Trends
15.2 Natamycin Drivers
15.3 Natamycin Market Challenges
15.4 Natamycin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Natamycin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Natamycin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Natamycin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Natamycin Sales (K Units) by Region (2016-2021)
Table 5. Global Natamycin Sales Market Share by Region (2016-2021)
Table 6. Global Natamycin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Natamycin Revenue Share by Region (2016-2021)
Table 8. Global Natamycin Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Natamycin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Natamycin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Natamycin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Natamycin Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Natamycin Sales Share by Company (2016-2021)
Table 14. Global Natamycin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Natamycin Revenue Share by Company (2016-2021)
Table 16. Global Natamycin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natamycin as of 2020)
Table 17. Global Natamycin Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Natamycin Manufacturing Sites and Area Served
Table 19. Manufacturers Natamycin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Natamycin Sales (K Units) by Type (2016-2021)
Table 22. Global Natamycin Sales Share by Type (2016-2021)
Table 23. Global Natamycin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Natamycin Price (USD/Unit) by Type (2016-2021)
Table 25. Global Natamycin Sales Share by Type (2022-2027)
Table 26. Global Natamycin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Natamycin Revenue Share by Type (2022-2027)
Table 28. Global Natamycin Price (USD/Unit) by Type (2022-2027)
Table 29. Global Natamycin Sales (K Units) by Application (2016-2021)
Table 30. Global Natamycin Sales Share by Application (2016-2021)
Table 31. Global Natamycin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Natamycin Price (USD/Unit) by Application (2016-2021)
Table 33. Global Natamycin Sales (K Units) by Application (2022-2027)
Table 34. Global Natamycin Sales Share by Application (2022-2027)
Table 35. Global Natamycin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Natamycin Revenue Share by Application (2022-2027)
Table 37. Global Natamycin Price (USD/Unit) by Application (2022-2027)
Table 38. North America Natamycin Sales (K Units) by Company (2016-2021)
Table 39. North America Natamycin Sales Market Share by Company (2016-2021)
Table 40. North America Natamycin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Natamycin Revenue Market Share by Company (2016-2021)
Table 42. North America Natamycin Sales by Type (2016-2021) & (K Units)
Table 43. North America Natamycin Sales Market Share by Type (2016-2021)
Table 44. North America Natamycin Sales by Type (2022-2027) & (K Units)
Table 45. North America Natamycin Sales Market Share by Type (2022-2027)
Table 46. North America Natamycin Sales by Application (2016-2021) & (K Units)
Table 47. North America Natamycin Sales Market Share by Application (2016-2021)
Table 48. North America Natamycin Sales by Application (2022-2027) & (K Units)
Table 49. North America Natamycin Sales Market Share by Application (2022-2027)
Table 50. Europe Natamycin Sales (K Units) by Company (2016-2021)
Table 51. Europe Natamycin Sales Market Share by Company (2016-2021)
Table 52. Europe Natamycin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Natamycin Revenue Market Share by Company (2016-2021)
Table 54. Europe Natamycin Sales by Type (2016-2021) & (K Units)
Table 55. Europe Natamycin Sales Market Share by Type (2016-2021)
Table 56. Europe Natamycin Sales by Type (2022-2027) & (K Units)
Table 57. Europe Natamycin Sales Market Share by Type (2022-2027)
Table 58. Europe Natamycin Sales by Application (2016-2021) & (K Units)
Table 59. Europe Natamycin Sales Market Share by Application (2016-2021)
Table 60. Europe Natamycin Sales by Application (2022-2027) & (K Units)
Table 61. Europe Natamycin Sales Market Share by Application (2022-2027)
Table 62. China Natamycin Sales (K Units) by Company (2016-2021)
Table 63. China Natamycin Sales Market Share by Company (2016-2021)
Table 64. China Natamycin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Natamycin Revenue Market Share by Company (2016-2021)
Table 66. China Natamycin Sales by Type (2016-2021) & (K Units)
Table 67. China Natamycin Sales Market Share by Type (2016-2021)
Table 68. China Natamycin Sales by Type (2022-2027) & (K Units)
Table 69. China Natamycin Sales Market Share by Type (2022-2027)
Table 70. China Natamycin Sales by Application (2016-2021) & (K Units)
Table 71. China Natamycin Sales Market Share by Application (2016-2021)
Table 72. China Natamycin Sales by Application (2022-2027) & (K Units)
Table 73. China Natamycin Sales Market Share by Application (2022-2027)
Table 74. Japan Natamycin Sales (K Units) by Company (2016-2021)
Table 75. Japan Natamycin Sales Market Share by Company (2016-2021)
Table 76. Japan Natamycin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Natamycin Revenue Market Share by Company (2016-2021)
Table 78. Japan Natamycin Sales by Type (2016-2021) & (K Units)
Table 79. Japan Natamycin Sales Market Share by Type (2016-2021)
Table 80. Japan Natamycin Sales by Type (2022-2027) & (K Units)
Table 81. Japan Natamycin Sales Market Share by Type (2022-2027)
Table 82. Japan Natamycin Sales by Application (2016-2021) & (K Units)
Table 83. Japan Natamycin Sales Market Share by Application (2016-2021)
Table 84. Japan Natamycin Sales by Application (2022-2027) & (K Units)
Table 85. Japan Natamycin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Natamycin Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Natamycin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Natamycin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Natamycin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Natamycin Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Natamycin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Natamycin Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Natamycin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Natamycin Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Natamycin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Natamycin Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Natamycin Sales Market Share by Application (2022-2027)
Table 98. India Natamycin Sales (K Units) by Company (2016-2021)
Table 99. India Natamycin Sales Market Share by Company (2016-2021)
Table 100. India Natamycin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Natamycin Revenue Market Share by Company (2016-2021)
Table 102. India Natamycin Sales by Type (2016-2021) & (K Units)
Table 103. India Natamycin Sales Market Share by Type (2016-2021)
Table 104. India Natamycin Sales by Type (2022-2027) & (K Units)
Table 105. India Natamycin Sales Market Share by Type (2022-2027)
Table 106. India Natamycin Sales by Application (2016-2021) & (K Units)
Table 107. India Natamycin Sales Market Share by Application (2016-2021)
Table 108. India Natamycin Sales by Application (2022-2027) & (K Units)
Table 109. India Natamycin Sales Market Share by Application (2022-2027)
Table 110. Danisco Corporation Information
Table 111. Danisco Description and Business Overview
Table 112. Danisco Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Danisco Natamycin Product
Table 114. Danisco Recent Development
Table 115. DSM Corporation Information
Table 116. DSM Description and Business Overview
Table 117. DSM Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. DSM Natamycin Product
Table 119. DSM Recent Development
Table 120. VGP Corporation Information
Table 121. VGP Description and Business Overview
Table 122. VGP Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. VGP Natamycin Product
Table 124. VGP Recent Development
Table 125. Handary Corporation Information
Table 126. Handary Description and Business Overview
Table 127. Handary Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Handary Natamycin Product
Table 129. Handary Recent Development
Table 130. AMTECH BIOTECH Corporation Information
Table 131. AMTECH BIOTECH Description and Business Overview
Table 132. AMTECH BIOTECH Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. AMTECH BIOTECH Natamycin Product
Table 134. AMTECH BIOTECH Recent Development
Table 135. Silver-Elephant Corporation Information
Table 136. Silver-Elephant Description and Business Overview
Table 137. Silver-Elephant Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Silver-Elephant Natamycin Product
Table 139. Silver-Elephant Recent Development
Table 140. Lanzhou Weiri Corporation Information
Table 141. Lanzhou Weiri Description and Business Overview
Table 142. Lanzhou Weiri Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Lanzhou Weiri Natamycin Product
Table 144. Lanzhou Weiri Recent Development
Table 145. Langfang Meihua Corporation Information
Table 146. Langfang Meihua Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Langfang Meihua Description and Business Overview
Table 148. Langfang Meihua Natamycin Product
Table 149. Langfang Meihua Recent Development
Table 150. Zhengzhou New Frey Corporation Information
Table 151. Zhengzhou New Frey Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Zhengzhou New Frey Description and Business Overview
Table 153. Zhengzhou New Frey Natamycin Product
Table 154. Zhengzhou New Frey Recent Development
Table 155. Chihon Corporation Information
Table 156. Chihon Description and Business Overview
Table 157. Chihon Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Chihon Natamycin Product
Table 159. Chihon Recent Development
Table 160. Jiaozuo Joincare Corporation Information
Table 161. Jiaozuo Joincare Description and Business Overview
Table 162. Jiaozuo Joincare Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Jiaozuo Joincare Natamycin Product
Table 164. Jiaozuo Joincare Recent Development
Table 165. Beijing Oriental Rada Corporation Information
Table 166. Beijing Oriental Rada Description and Business Overview
Table 167. Beijing Oriental Rada Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Beijing Oriental Rada Natamycin Product
Table 169. Beijing Oriental Rada Recent Development
Table 170. Pucheng Lifecome Corporation Information
Table 171. Pucheng Lifecome Description and Business Overview
Table 172. Pucheng Lifecome Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Pucheng Lifecome Natamycin Product
Table 174. Pucheng Lifecome Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Natamycin Distributors List
Table 178. Natamycin Customers List
Table 179. Natamycin Market Trends
Table 180. Natamycin Market Drivers
Table 181. Natamycin Market Challenges
Table 182. Natamycin Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Natamycin Product Picture
Figure 2. Global Natamycin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Natamycin Sales Market Share by Application in 2021 & 2027
Figure 6. Food Industry Examples
Figure 7. Medical Examples
Figure 8. Others Examples
Figure 9. Global Natamycin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Natamycin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Natamycin Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Natamycin Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Natamycin Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Natamycin Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Natamycin Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Natamycin Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Natamycin Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Natamycin Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Natamycin Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Natamycin Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Natamycin Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Natamycin Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Natamycin Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Natamycin Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Natamycin Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Natamycin Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Natamycin Players Market Share by Revenue in Natamycin: 2016 & 2020
Figure 28. Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Natamycin Revenue Share by Type (2016-2021)
Figure 30. Global Natamycin Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Natamycin Revenue Share by Application (2016-2021)
Figure 32. Global Natamycin Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Natamycin Sales Market Share by Type in 2020
Figure 34. North America Natamycin Sales Market Share by Application in 2020
Figure 35. Europe Natamycin Sales Market Share by Type in 2020
Figure 36. Europe Natamycin Sales Market Share by Application in 2020
Figure 37. China Natamycin Sales Market Share by Type in 2020
Figure 38. China Natamycin Sales Market Share by Application in 2020
Figure 39. Japan Natamycin Sales Market Share by Type in 2020
Figure 40. Japan Natamycin Sales Market Share by Application in 2020
Figure 41. Southeast Asia Natamycin Sales Market Share by Type in 2020
Figure 42. Southeast Asia Natamycin Sales Market Share by Application in 2020
Figure 43. India Natamycin Sales Market Share by Type in 2020
Figure 44. India Natamycin Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Natamycin
Figure 47. Manufacturing Process Analysis of Natamycin
Figure 48. Natamycin Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
特別医療用食品（FSMP）のグローバル市場2021 Foods for special medical purposes (FSMP) are a sub-category of foods intended for particular nutritional uses (PARNUT), also called “dietetic foods.” FSMPs are intended for the dietary management of diseases in patients with impaired digestive function such as absorption, making them the most medic…- 医療用サイクロトロンのグローバル市場2021 Medical Cyclotron is a cyclotron that is a type of compact particle accelerator used to produce quantities of radioactive isotopes called positron emitters. Stable, non-radioactive isotopes are put into the cyclotron which accelerates charged particles to high energy in a magnetic field. The stable …
- 医療用線形加速器のグローバル市場2021 A linear accelerator is a device that uses high Radio-Frequency (RF) electromagnetic waves to accelerate charged particles (i.e. electrons) to high energies in a linear path, inside a tube like structure called the accelerator waveguide. The resonating cavity frequency of the medical linacs is about…
- 食品用L-アラビノースのグローバル市場2021 L-arabinose, also known as gum aldose, pectin sugar, which is found in glia, hemicellulose, pectic acid, bacterial polysaccharides and certain glycosides in the form of heteropolysaccharides, having a high stability to heat and acid. North America is the world's largest market, accounting for about …
- 食品・飲料用積層鋼のグローバル市場2021 Laminated Steel is a kind of composite material that stick plastic films to cold-rolled steel sheet, it is also a kind of steel deep-processing product. Laminated Steel does not contain harmful substances, the subsequent production process is also very environmentally friendly, and the production co…